SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001250853-17-000093
Filing Date
2017-10-20
Accepted
2017-10-20 14:19:39
Documents
1
Period of Report
2017-10-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 4143
  Complete submission text file 0001250853-17-000093.txt   5820
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2120 HEMLOCK RD. WEST NORRITON PA 19403
Business Address
Vogt Frederick G (Reporting) CIK: 0001719678 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36860 | Film No.: 171146773